Your browser doesn't support javascript.
loading
Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate.
Lelle, Marco; Kaloyanova, Stefka; Freidel, Christoph; Theodoropoulou, Marily; Musheev, Michael; Niehrs, Christof; Stalla, Günter; Peneva, Kalina.
Afiliação
  • Lelle M; Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
  • Kaloyanova S; Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
  • Freidel C; Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
  • Theodoropoulou M; Max Planck Institute for Psychiatry, Kraepelinstraße 2-10, 80804 Munich, Germany.
  • Musheev M; Institute of Molecular Biology, Ackermannweg 4, 55128 Mainz, Germany.
  • Niehrs C; Institute of Molecular Biology, Ackermannweg 4, 55128 Mainz, Germany.
  • Stalla G; Division of Molecular Embryology, DKFZ-ZMBH Alliance , 69120 Heidelberg, Germany.
  • Peneva K; Max Planck Institute for Psychiatry, Kraepelinstraße 2-10, 80804 Munich, Germany.
Mol Pharm ; 12(12): 4290-300, 2015 Dec 07.
Article em En | MEDLINE | ID: mdl-26524088
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Octreotida / Doxorrubicina Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Octreotida / Doxorrubicina Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article